UroGen Pharma Ltd. (URGN) Earnings
NASDAQ·Healthcare·Biotechnology
$41.61
-2.69%
Mkt Cap $2.03B
EPS — Estimate vs Actual
Mkt Cap
$2.03B
P/E
—
Fwd P/E
—
P/S
18.52
Rev TTM
—
EPS TTM
-$3.20
NASDAQ·Healthcare·Biotechnology
$41.61
-2.69%
Mkt Cap $2.03B
Mkt Cap
$2.03B
P/E
—
Fwd P/E
—
P/S
18.52
Rev TTM
—
EPS TTM
-$3.20